Loading…

Loading grant details…

Active HORIZON European Commission

Metabolic control of cell growth by mTOR in health and disease: a multi-disciplinary training


Funder European Commission
Recipient Organization Universite Paris Cite
Country France
Start Date Jan 01, 2025
End Date Dec 31, 2028
Duration 1,460 days
Number of Grantees 26
Roles Participant; Associated Partner; Coordinator
Data Source European Commission
Grant ID 101168624
Grant Description

MENTOR is a multi-disciplinary training network which focuses on the mTOR pathway, a central mechanistic hub that integrates nutritional cues and controls cell growth and metabolism.

Aberrant activation of mTOR underlies monogenic diseases with broad spectrum of pathological manifestations, including tissue overgrowth, polycystic kidneys and neuropsychiatric disorders affecting around two million of people worldwide.

To avoid the medical errancy of patients in different clinical departments and surgical mutilations, approaches of personalized medicine depending on the genetic landscape need to be implemented, taking advantage of suitable pharmacological products.

The overall goal of the MENTOR research program is to: delineate molecular mechanisms of fundamental and aberrant mTOR functions, preclinically decipher the pathophysiology of mTOR, develop a novel arsenal of drugs to selectively target the pathway and provide proof-of-concept support for such interventions.

This ambition can only be achieved by the multidisciplinary research program that MENTOR has conceived, through the training of a new generation of scientists at Graduate Schools of biology, pharmacy, chemistry or medicine that will become the leaders of mTOR research in both public and private sectors.

MENTOR will establish a collaborative and efficient network from academia to industry, involving patient associations and clinicians with impact on scientific community and society.

All Grantees

Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos Iii; Mimetas Bv; Miedzynarodowy Instytut Mechanizmow I Maszyn Molekularnych Polskiej Akademii Nauk; Fondazione Telethon Ets; Pd-Value Bv; Institut National de la Sante Et de la Recherche Medicale; Universitat Basel; The Myrovlytis Trust; Assistance Publique Hopitaux de Paris; Universita Degli Studi Di Napoli Federico Ii; Idryma Technologias Kai Erevnas; Institut Du Cerveau Et de la Moelle Epiniere; European Tuberous Sclerosis Complex Association (E-Tsc); Biosolveit Gmbh; Topadur Pharma Ag; Universitair Medisch Centrum Utrecht; Universitaetsklinikum Essen; Cell Signaling Technology, Inc.; Universite Paris Cite; Panepistimio Ioanninon; Eberhard Karls Universitaet Tuebingen; Universidad Autonoma de Madrid; Katholieke Universiteit Leuven; Universite de Fribourg; Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej W Warszawie; Sorbonne Universite

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant